Home › Asset managers › Jackson National › 2024-2025 › Against the board
At least 6,056 proposals in the 2024-2025 proxy season: Jackson National voted against, or withheld its votes from, at least 6,000 proposals put forward by company boards, and voted for 56 shareholder proposals, by its own Form N-PX filings.
Two kinds of vote are listed: a board-sponsored proposal Jackson National voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,056 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Jackson National voted | Funds |
|---|---|---|---|---|---|---|---|
| ZEDGE INC | January 15, 2025 | To approve an amendment to the Zedge, Inc. 2016 Stock Option and Inventive Plan that will increase the number of shares of the Company's Class B common stock available for the grant of awards thereunder by 100,000. | Compensation | Board | AGAINST | 2 | |
| ZENTALIS PHARMACEUTICALS, INC. | June 17, 2025 | DIRECTOR: Karan Takhar | Director Elections | Board | ABSTAIN | 2 | |
| ZENTALIS PHARMACEUTICALS, INC. | June 17, 2025 | DIRECTOR: Luke Walker, M.D | Director Elections | Board | ABSTAIN | 2 | |
| ZENTALIS PHARMACEUTICALS, INC. | June 17, 2025 | DIRECTOR: Scott Myers | Director Elections | Board | ABSTAIN | 2 | |
| ZENTALIS PHARMACEUTICALS, INC. | June 17, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| ZETA GLOBAL HOLDINGS CORP. | June 9, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers | Say-on-Pay | Board | AGAINST | 2 | |
| ZETA GLOBAL HOLDINGS CORP. | June 9, 2025 | Election of Director: William Royan | Director Elections | Board | WITHHOLD | 2 | |
| ZIFF DAVIS, INC. | May 7, 2025 | To provide an advisory vote on the compensation of Ziff Davis' named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| ZIJIN MINING GROUP CO LTD | May 19, 2025 | TO CONSIDER AND APPROVE THE PROPOSAL IN RELATION TO A GENERAL MANDATE TO ISSUE DEBT FINANCING INSTRUMENTS OF THE COMPANY | Capital Structure | Board | AGAINST | 2 | |
| ZIJIN MINING GROUP CO LTD | May 19, 2025 | TO CONSIDER AND APPROVE THE PROPOSAL IN RELATION TO THE PLAN OF GUARANTEES FOR THE YEAR ENDING 31 DECEMBER 2025 | Capital Structure | Board | AGAINST | 2 | |
| ZIMVIE INC. | May 7, 2025 | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). | Say-on-Pay | Board | AGAINST | 2 | |
| ZOOMINFO TECHNOLOGIES INC. | May 14, 2025 | DIRECTOR: Ashley S. Evans | Director Elections | Board | ABSTAIN | 2 | |
| ZOOMINFO TECHNOLOGIES INC. | May 14, 2025 | DIRECTOR: Mark Mader | Director Elections | Board | ABSTAIN | 2 | |
| ZTO EXPRESS (CAYMAN) INC | June 17, 2025 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT, AND DEAL WITH ADDITIONAL CLASS A ORDINARY SHARES OF THE COMPANY NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED AND OUTSTANDING SHARES OF THE COMPANY AS AT THE DATE OF PASSING OF THIS RESOLUTION | Capital Structure | Board | AGAINST | 2 | |
| ZYMEWORKS INC. | December 10, 2024 | DIRECTOR: Kelvin Neu | Director Elections | Board | ABSTAIN | 2 | |
| ZYMEWORKS INC. | December 10, 2024 | DIRECTOR: Kenneth Galbraith | Director Elections | Board | ABSTAIN | 2 | |
| ZYMEWORKS INC. | December 10, 2024 | DIRECTOR: Susan Mahony | Director Elections | Board | ABSTAIN | 2 | |
| 1-800-FLOWERS.COM, INC. | December 11, 2024 | DIRECTOR: Celia R. Brown | Director Elections | Board | ABSTAIN | 1 | |
| 1-800-FLOWERS.COM, INC. | December 11, 2024 | DIRECTOR: Christina Shim | Director Elections | Board | ABSTAIN | 1 | |
| 1-800-FLOWERS.COM, INC. | December 11, 2024 | DIRECTOR: Christopher G. McCann | Director Elections | Board | ABSTAIN | 1 | |
| 1-800-FLOWERS.COM, INC. | December 11, 2024 | DIRECTOR: James F. McCann | Director Elections | Board | ABSTAIN | 1 | |
| 1-800-FLOWERS.COM, INC. | December 11, 2024 | DIRECTOR: Larry Zarin | Director Elections | Board | ABSTAIN | 1 | |
| 1-800-FLOWERS.COM, INC. | December 11, 2024 | DIRECTOR: Leonard J. Elmore | Director Elections | Board | ABSTAIN | 1 | |
| 1-800-FLOWERS.COM, INC. | December 11, 2024 | DIRECTOR: Stephanie R. Hofmann | Director Elections | Board | ABSTAIN | 1 | |
| 1STDIBS.COM, INC. | May 8, 2025 | DIRECTOR: David S. Rosenblatt | Director Elections | Board | ABSTAIN | 1 | |
| 1STDIBS.COM, INC. | May 8, 2025 | DIRECTOR: Everette Taylor | Director Elections | Board | ABSTAIN | 1 | |
| 1STDIBS.COM, INC. | May 8, 2025 | DIRECTOR: Paula J. Volent | Director Elections | Board | ABSTAIN | 1 | |
| 360 SECURITY TECHNOLOGY INC. | May 16, 2025 | 2025 ESTIMATED EXTERNAL GUARANTEE QUOTA OF THE COMPANY AND SUBSIDIARIES | Capital Structure | Board | AGAINST | 1 | |
| 3M COMPANY | May 13, 2025 | Election of Director for a term of one year: Gregory R. Page | Director Elections | Board | AGAINST | 1 | |
| 3M COMPANY | May 13, 2025 | To ratify the appointment of PricewaterhouseCoopers LLP as 3M's independent registered public accounting firm. | Audit-related | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO APPROVE AND ADOPT THE 2025 SHARE AWARD SCHEME | Compensation | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO APPROVE AND ADOPT THE 2025 SHARE OPTION SCHEME | Compensation | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO APPROVE AND ADOPT THE SCHEME MANDATE LIMIT (NEW SHARES SHARE AWARD) UNDER THE 2025 SHARE AWARD SCHEME | Capital Structure | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO APPROVE AND ADOPT THE SCHEME MANDATE LIMIT (SHARE AWARD) UNDER THE 2025 SHARE AWARD SCHEME | Capital Structure | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO APPROVE AND ADOPT THE SCHEME MANDATE LIMIT (SHARE OPTION) UNDER THE 2025 SHARE OPTION SCHEME | Compensation | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO APPROVE AND ADOPT THE SERVICE PROVIDER SUB-LIMIT (NEW SHARES SHARE AWARD) UNDER THE 2025 SHARE AWARD SCHEME | Capital Structure | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO APPROVE AND ADOPT THE SERVICE PROVIDER SUB-LIMIT (SHARE OPTION) UNDER THE 2025 SHARE OPTION SCHEME | Compensation | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES OUT OF TREASURY) BY THE AGGREGATE NUMBER OF SHARES REPURCHASED BY THE COMPANY | Capital Structure | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES OUT OF TREASURY) NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY (EXCLUDING ANY TREASURY SHARES) AS AT THE DATE OF PASSING OF THIS RESOLUTION | Capital Structure | Board | AGAINST | 1 | |
| 3SBIO INC | June 25, 2025 | TO TERMINATE THE SHARE AWARD SCHEME ADOPTED BY THE COMPANY ON 16 JULY 2019 AND AMENDED ON 12 DECEMBER 2021 | Compensation | Board | AGAINST | 1 | |
| 4D MOLECULAR THERAPEUTICS, INC. | June 17, 2025 | Election of Class II director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jacob Chacko, M.D., MBA | Director Elections | Board | WITHHOLD | 1 | |
| 89BIO, INC. | May 28, 2025 | Approval of, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| 89BIO, INC. | May 28, 2025 | DIRECTOR: Derek DiRocco, Ph.D. | Director Elections | Board | ABSTAIN | 1 | |
| 89BIO, INC. | May 28, 2025 | DIRECTOR: Lota Zoth, C.P.A. | Director Elections | Board | ABSTAIN | 1 | |
| 89BIO, INC. | May 28, 2025 | DIRECTOR: Martin Babler | Director Elections | Board | ABSTAIN | 1 | |
| AAC TECHNOLOGIES HOLDINGS INC | May 22, 2025 | TO APPROVE AND ADOPT THE PROPOSED AMENDMENTS TO THE SHARE AWARD SCHEME OF THE COMPANY ADOPTED ON 17 APRIL 2023 (THE SCHEME), AND TO APPROVE AND ADOPT THE SCHEME AFTER INCORPORATING SUCH AMENDMENTS (ORDINARY RESOLUTION SET OUT IN ITEM 8 OF THE NOTICE OF ANNUAL GENERAL MEETING) | Compensation | Board | AGAINST | 1 | |
| AAC TECHNOLOGIES HOLDINGS INC | May 22, 2025 | TO EXTEND THE GENERAL MANDATE TO ISSUE NEW SHARES AND/OR RESELL OR TRANSFER TREASURY SHARES OF THE COMPANY BY ADDITION THERETO THE SHARES REPURCHASED BY THE COMPANY (ORDINARY RESOLUTION SET OUT IN ITEM 7 OF THE NOTICE OF ANNUAL GENERAL MEETING) | Capital Structure | Board | AGAINST | 1 | |
| AAC TECHNOLOGIES HOLDINGS INC | May 22, 2025 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE SHARES AND/OR RESELL OR TRANSFER TREASURY SHARES OF THE COMPANY (ORDINARY RESOLUTION SET OUT IN ITEM 5 OF THE NOTICE OF ANNUAL GENERAL MEETING) | Capital Structure | Board | AGAINST | 1 | |
| AADI BIOSCIENCE, INC. | February 28, 2025 | Equity Plan Increase Proposal: To approve an amendment to the Aadi Bioscience, Inc. 2021 Equity Incentive (the "2021 Plan") to (i) increase the shares available for issuance under the 2021 Plan by 6,300,000 shares from 2,000,284 shares to 8,300,284 shares and (ii) increase the 2021 Plan's default annual automatic share reserve increase occurring on January 1 of each year from 4% of outstanding shares on the last day of the immediately preceding fiscal year to 5%. | Compensation | Board | AGAINST | 1 | |
| AADI BIOSCIENCE, INC. | February 28, 2025 | The PIPE Financing Proposal: To approve, for purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635, the issuance of an aggregate of 21,592,000 shares of Aadi's common stock, par value $0.0001 per share, at a price of $2.40 per share and pre-funded warrants to purchase up to an aggregate of 20,076,500 shares of Aadi's common stock at a purchase price of $2.3999 per pre-funded warrant. | Capital Structure | Board | AGAINST | 1 | |
| AB SAGAX | May 8, 2025 | RE-ELECTION OF STAFFAN SALEN AS A MEMBER OF THE BOARD OF DIRECTORS | Director Elections | Board | AGAINST | 1 | |
| ABBVIE INC. | May 9, 2025 | Election of Class I Director: Brett J. Hart | Director Elections | Board | AGAINST | 1 | |
| ABBVIE INC. | May 9, 2025 | Election of Class I Director: Edward J. Rapp | Director Elections | Board | AGAINST | 1 | |
| ABC-MART,INC. | May 27, 2025 | Appoint a Director who is not Audit and Supervisory Committee Member Noguchi, Minoru | Director Elections | Board | AGAINST | 1 | |
| ABC-MART,INC. | May 27, 2025 | Appoint a Director who is not Audit and Supervisory Committee Member Sasaki, Kanako | Director Elections | Board | AGAINST | 1 | |
| ABC-MART,INC. | May 27, 2025 | Appoint a Director who is not Audit and Supervisory Committee Member Suzuki, Hiroko | Director Elections | Board | AGAINST | 1 | |
| ABC-MART,INC. | May 27, 2025 | Approve Appropriation of Surplus | Capital Structure | Board | AGAINST | 1 | |
| ABDULLAH AL OTHAIM MARKETS COMPANY | October 1, 2024 | VOTING ON THE ELECTION OF THE BOARD OF DIRECTORS MEMBER FROM AMONG THE NOMINEES FOR THE NEXT THREE-YEARS SESSION WHICH BEGINS ON 03/10/2024 AND ENDS ON 02/10/2027: MR. ABDULLAH SALEH ALI AL-OTHAIM | Director Elections | Board | ABSTAIN | 1 | |
| ABOITIZ POWER CORP | April 28, 2025 | APPOINTMENT OF THE COMPANYS EXTERNAL AUDITOR FOR 2025: SYCIP GORRES VELAYO AND CO | Audit-related | Board | AGAINST | 1 | |
| ABOITIZ POWER CORP | April 28, 2025 | ELECTION OF DIRECTOR: ANTONIO A. CANOVA | Director Elections | Board | ABSTAIN | 1 | |
| ABOITIZ POWER CORP | April 28, 2025 | ELECTION OF DIRECTOR: CESAR G. ROMERO (INDEPENDENT DIRECTOR) | Director Elections | Board | ABSTAIN | 1 | |
| ABOITIZ POWER CORP | April 28, 2025 | ELECTION OF DIRECTOR: ERIC RAMON O. RECTO (INDEPENDENT DIRECTOR) | Director Elections | Board | ABSTAIN | 1 | |
| ABOITIZ POWER CORP | April 28, 2025 | ELECTION OF DIRECTOR: ERRAMON I. ABOITIZ | Director Elections | Board | ABSTAIN | 1 | |
| ABOITIZ POWER CORP | April 28, 2025 | ELECTION OF DIRECTOR: IZUMI KAI | Director Elections | Board | ABSTAIN | 1 | |
| ABU DHABI ISLAMIC BANK | March 10, 2025 | ELECTION OF THE BANK BOARD OF DIRECTORS FOR THREE YEARS | Director Elections | Board | AGAINST | 1 | |
| ABU DHABI NATIONAL OIL COMPANY FOR DISTRIBUTION PJ | March 25, 2025 | APPROVE THE BOARD OF DIRECTORS REMUNERATION FOR THE FINANCIAL YEAR ENDED 31 DEC 2024 | Compensation | Board | AGAINST | 1 | |
| ABU DHABI PORTS COMPANY PJSC | December 20, 2024 | RATIFY THE APPOINTMENT OF H.E MOHAMED HASSAN ALSUWAIDI AS BOARD MEMBER | Director Elections | Board | AGAINST | 1 | |
| ABU DHABI PORTS COMPANY PJSC | April 21, 2025 | APPROVE REMUNERATION OF DIRECTORS FOR FY 2024 | Compensation | Board | AGAINST | 1 | |
| ABU DHABI PORTS COMPANY PJSC | April 21, 2025 | ELECT 9 MEMBERS OF BOARD OF DIRECTORS FOR A NEW TERM OF THREE YEARS | Director Elections | Board | AGAINST | 1 | |
| AC IMMUNE SA | June 19, 2025 | Advisory vote on the 2024 Compensation Report | Say-on-Pay | Board | AGAINST | 1 | |
| AC IMMUNE SA | June 19, 2025 | Binding vote on Maximum Aggregate Compensation for Members of the Board of Directors from the AGM 2025 to the AGM 2026 | Compensation | Board | AGAINST | 1 | |
| AC IMMUNE SA | June 19, 2025 | Capital band (Article 3a) | Capital Structure | Board | AGAINST | 1 | |
| AC IMMUNE SA | June 19, 2025 | Increase and amendment of conditional share capital for employee-benefit plans (Article 3c paras. 1 and 3) | Capital Structure | Board | AGAINST | 1 | |
| AC IMMUNE SA | June 19, 2025 | Re-election of Director: Monika Bütler | Director Elections | Board | AGAINST | 1 | |
| AC IMMUNE SA | June 19, 2025 | Re-election of Director: Roy Twyman | Director Elections | Board | AGAINST | 1 | |
| ACADIA HEALTHCARE COMPANY, INC. | May 29, 2025 | Election of Director: Reeve B. Waud | Director Elections | Board | AGAINST | 1 | |
| ACCENTURE PLC | February 6, 2025 | Appointment of Director: Arun Sarin | Director Elections | Board | AGAINST | 1 | |
| ACCENTURE PLC | February 6, 2025 | Appointment of Director: Jaime Ardila | Director Elections | Board | AGAINST | 1 | |
| ACCESS NEWSWIRE, INC. | June 13, 2025 | Election of Director: Brian R. Balbirnie (Director, President, Chief Executive Officer and Chairperson of the Board Corporation) | Director Elections | Board | AGAINST | 1 | |
| ACCIONA SA | June 25, 2025 | ADVISORY VOTE ON THE ANNUAL DIRECTORS' REMUNERATION REPORT FOR 2024 | Say-on-Pay | Board | AGAINST | 1 | |
| ACCIONA SA | June 25, 2025 | APPROVAL OF THE DIRECTORS' REMUNERATION POLICY FOR THE FINANCIAL YEARS 2026, 2027 AND 2028 | Compensation | Board | AGAINST | 1 | |
| ACCIONA SA | June 25, 2025 | RE-ELECT MR. CARLO CLAVARINO AS INDEPENDENT DIRECTOR | Director Elections | Board | AGAINST | 1 | |
| ACCIONA SA | June 25, 2025 | RE-ELECT MS. MAITE ARANGO GARCIA-URTIAGA AS INDEPENDENT DIRECTOR | Director Elections | Board | AGAINST | 1 | |
| ACCO BRANDS CORPORATION | May 20, 2025 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares reserved for issuance. | Compensation | Board | AGAINST | 1 | |
| ACCOR SA | May 28, 2025 | RENEWAL OF MR. NICOLAS SARKOZYS MANDATE AS DIRECTOR OF THE COMPANY | Director Elections | Board | ABSTAIN | 1 | |
| ACCOR SA | May 28, 2025 | RENEWAL OF MR. NICOLAS SARKOZYS MANDATE AS DIRECTOR OF THE COMPANY | Director Elections | Board | AGAINST | 1 | |
| ACCTON TECHNOLOGY CORPORATION | June 12, 2025 | THE ELECTION OF THE DIRECTOR.:GOLDEN TENGIS CO., LTD,SHAREHOLDER NO.192057 | Director Elections | Board | AGAINST | 1 | |
| ACLARIS THERAPEUTICS, INC. | June 5, 2025 | DIRECTOR: Andrew Schiff | Director Elections | Board | ABSTAIN | 1 | |
| ACLARIS THERAPEUTICS, INC. | June 5, 2025 | DIRECTOR: Neal Walker | Director Elections | Board | ABSTAIN | 1 | |
| ACLARIS THERAPEUTICS, INC. | June 5, 2025 | DIRECTOR: William Humphries | Director Elections | Board | ABSTAIN | 1 | |
| ACLARIS THERAPEUTICS, INC. | June 5, 2025 | To approve the Aclaris Therapeutics, Inc. 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| ACLARIS THERAPEUTICS, INC. | June 5, 2025 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. | Say-on-Pay | Board | AGAINST | 1 | |
| ACS, ACTIVIDADES DE CONSTRUCCION Y SERVICIOS SA | May 8, 2025 | DIRECTORS' REMUNERATION: ADVISORY VOTE ON THE 2024 ANNUAL DIRECTORS' REMUNERATION REPORT | Say-on-Pay | Board | AGAINST | 1 | |
| ACUMEN PHARMACEUTICALS, INC. | June 4, 2025 | Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: Kimberlee C. Drapkin | Director Elections | Board | WITHHOLD | 1 | |
| ACWA POWER | January 2, 2025 | VOTING ON THE ELECTION OF THE MEMBER OF THE BOARD OF DIRECTORS FROM AMONG THE NOMINEES FOR THE NEXT SESSION WHICH BEGINS ON 05/01/2025 FOR A TERM THAT WILL BE DETERMINED IN ACCORDANCE TO VOTING RESULT OF AGENDA NO (1): MR. ABDULELAH AHMED ABDULAZIZ AL-AHMED | Director Elections | Board | ABSTAIN | 1 | |
| ACWA POWER | January 2, 2025 | VOTING ON THE RESOLUTION OF THE BOARD OF DIRECTORS TO APPOINT A (NON-EXECUTIVE) BOARD MEMBER STARTING FROM THE DATE OF HIS APPOINTMENT ON 15/10/2023 TO COMPLETE THE BOARD TERM UNTIL THE END OF THE CURRENT TERM ON 04/01/2025: MR. ABDULLAH FAHAD ABDULJABBAR | Director Elections | Board | AGAINST | 1 | |
| ACWA POWER | June 30, 2025 | VOTING ON THE AMENDMENT OF REMUNERATION POLICY FOR MEMBERS OF THE BOARD, ITS COMMITTEE, AND EXECUTIVE MANAGEMENT | Compensation | Board | AGAINST | 1 | |
| ACWA POWER | June 30, 2025 | VOTING ON THE COMPANY S PURCHASE OF ITS SHARES WITH A MAXIMUM OF (1,608,478) SHARES FOR THE PURPOSE OF ALLOCATING THEM TO THE EMPLOYEES STOCK INCENTIVE PROGRAM, THE PURCHASE WILL BE FINANCED THROUGH THE COMPANY OWN RESOURCES, PROVIDED THAT THE BOARD OF DIRECTORS IS AUTHORIZED TO COMPLETE THE PURCHASE WITHIN A MAXIMUM PERIOD OF EIGHTEEN MONTHS FROM THE DATE OF THE RESOLUTION OF THE EXTRAORDINARY GENERAL ASSEMBLY, THE COMPANY MAY HOLD THE PURCHASED SHARES FOR A PERIOD NOT EXCEEDING (7) YEARS FROM THE DATE OF APPROVAL OF THE EXTRAORDINARY GENERAL ASSEMBLY AS A MAXIMUM UNTIL THEY ARE ALLOCATED TO THE EMPLOYEES STOCK INCENTIVE PROGRAM, AND ONCE 7 YEARS PERIOD LAPSES, THE COMPANY WILL FOLLOW THE PROCEDURES AND CONTROLS STIPULATED IN THE RELEVANT LAWS AND REGULATIONS. THE ASSEMBLY AUTHORIZE THE BOARD OF DIRECTORS TO DETERMINE THE TERMS OF THIS PROGRAM, INCLUDING THE ALLOCATION PRICE FOR EACH SHARE OFFERED TO EMPLOYEES IF IT IS FOR A CONSIDERATION | Capital Structure | Board | AGAINST | 1 | |
| ACWA POWER | June 30, 2025 | VOTING ON THE RECOMMENDATION OF THE BOARD OF DIRECTORS REGARDING THE INCREASE OF THE COMPANY S SHARE CAPITAL WITH A TOTAL OFFERING VALUE OF SAR (7,124,999,700), THROUGH RIGHTS ISSUE, PROVIDED THAT THE COMPANY WILL ANNOUNCE THE PROPOSED DETAILS RELATED TO THE NUMBER OF NEW SHARES, OFFER PRICE AND THE RESULTING SHARE CAPITAL INCREASE POST MARKET CLOSE ON THE EXTRAORDINARY GENERAL ASSEMBLY MEETING DAY AND BEFORE THE EXTRAORDINARY GENERAL ASSEMBLY MEETING, AND PRESENT SUCH DETAILS RELATED TO THE NUMBER OF NEW SHARES, OFFER PRICE AND THE RESULTING SHARE CAPITAL INCREASE TO THE SHAREHOLDERS DURING THE EXTRAORDINARY GENERAL ASSEMBLY MEETING FOR APPROVAL. THE SUBSCRIPTION TO THE RIGHTS ISSUE SHARES WILL BE IN ACCORDANCE WITH THE SUBSCRIPTION TERMS AND CONDITIONS SET OUT IN THE PROSPECTUS PUBLISHED BY THE COMPANY | Capital Structure | Board | AGAINST | 1 | |
| ADANI ENTERPRISES LTD | June 24, 2025 | RESOLVED THAT PURSUANT TO THE PROVISIONS OF SECTIONS 149, 152 AND SCHEDULE IV AND ALL OTHER APPLICABLE PROVISIONS, IF ANY, OF THE COMPANIES ACT, 2013 (ACT) AND THE COMPANIES (APPOINTMENT AND QUALIFICATION OF DIRECTORS) RULES, 2014 (INCLUDING ANY STATUTORY MODIFICATION(S) OR RE-ENACTMENT THEREOF FOR THE TIME BEING IN FORCE) AND IN ACCORDANCE WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENTS) REGULATIONS, 2015, AS AMENDED FROM TIME TO TIME, DR. OMKAR GOSWAMI (DIN: 00004258), WHO WAS APPOINTED AS AN INDEPENDENT DIRECTOR AND WHO HOLD OFFICE UPTO NOVEMBER 2, 2025 AND WHO IS ELIGIBLE FOR RE-APPOINTMENT AND IN RESPECT OF WHOM THE COMPANY HAS RECEIVED A NOTICE IN WRITING UNDER SECTION 160 OF THE ACT FROM A MEMBERS PROPOSING HIS CANDIDATURE FOR THE OFFICE OF DIRECTOR, BE AND IS HEREBY RE-APPOINTED AS AN INDEPENDENT DIRECTOR OF THE COMPANY, NOT LIABLE TO RETIRE BY ROTATION, TO HOLD OFFICE FOR A SECOND TERM OF 3 (THREE) YEARS UPTO NOVEMBER 2, 2028 ON THE BOARD OF THE COMPANY | Director Elections | Board | AGAINST | 1 |
← Previous Page 39 of 61 Next →
← Back to Jackson National 2024-2025 overview
Built November 8, 2026 from SEC Form N-PX filings.